WC
BMRN icon

Woodstock Corp’s BioMarin Pharmaceuticals BMRN Stock Holding History

Woodstock Corp’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$491K Hold
8,176
– – 0.04% 117
2026
Q2 		$468K Hold
8,176
– – 0.04% 121
2026
Q1 		$462K Hold
8,176
– – 0.04% 119
2025
Q4 		$486K Hold
8,176
– – 0.04% 116
2025
Q3 		$443K Buy
+8,176
New +$468K 0.04% 123

Other funds holding BMRN

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $11B AUM 34.31% 1-Year Est. Return
FFBTD
First Financial Bank - Trust Division Hamilton, Ohio $1.39B AUM 15.59% 1-Year Est. Return
KF
Krilogy Financial St. Louis, Missouri $3.66B AUM 22.28% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $880M AUM 10.53% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.62B AUM 25.73% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
MGI
Miller Global Investments Dallas, Texas $124M AUM 25.7% 1-Year Est. Return
NAM
NorthCrest Asset Manangement Plymouth, Minnesota $4.24B AUM 32.82% 1-Year Est. Return
CPBTD
Central Pacific Bank - Trust Division Honolulu, Hawaii $952M AUM 25.15% 1-Year Est. Return

Woodstock Corp's BMRN Position: Q3 2026 in Review

Woodstock Corp held its BioMarin Pharmaceuticals (BMRN) position steady in Q3 2026 at 8,176 shares worth $491K. The position accounts for 0.04% of the portfolio, ranked #117.

Woodstock Corp first reported a position in BMRN in Q3 2025 and has held it in 5 quarters since. 25 funds tracked by Wall St. Rank hold BMRN as of Q3 2026.

  • Woodstock Corp held 8,176 shares of BioMarin Pharmaceuticals worth $491K as of Q3 2026.
  • Woodstock Corp left its BioMarin Pharmaceuticals share count unchanged in Q3 2026.
  • BioMarin Pharmaceuticals made up 0.04% of Woodstock Corp's portfolio in Q3 2026, its #117 holding.
  • Woodstock Corp first reported a position in BioMarin Pharmaceuticals in Q3 2025 and has held it in 5 quarters since.
  • 25 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2026.

Based on Woodstock Corp's 13F filing for Q3 2026, filed 13 Oct 2026.